Rosalind Eeles

Rosalind Eeles is a prominent British oncologist and geneticist known for her significant contributions to the field of cancer genetics, particularly in prostate cancer research. She is a Professor of Oncogenetics at The Institute of Cancer Research and an Honorary Consultant in Clinical Oncology and Cancer Genetics at The Royal Marsden NHS Foundation Trust.

Early Life and Education

Rosalind Eeles was born in the United Kingdom. She pursued her medical degree at Cambridge University, where she developed an interest in oncology and genetics. She later completed her clinical training in oncology at St Bartholomew's Hospital and her PhD in cancer genetics at The Institute of Cancer Research.

Career

Eeles has dedicated her career to understanding the genetic basis of cancer, with a particular focus on prostate cancer. She has been instrumental in identifying genetic mutations that increase the risk of developing prostate cancer and has led numerous studies aimed at improving early detection and treatment.

Research Contributions

Eeles has been a key figure in several large-scale genetic studies, including the UK Genetic Prostate Cancer Study and the International Cancer Genome Consortium. Her research has led to the identification of multiple genetic variants associated with an increased risk of prostate cancer.

Awards and Honors

Throughout her career, Eeles has received numerous awards and honors for her contributions to cancer research. She is a Fellow of the Royal College of Physicians and the Academy of Medical Sciences. In recognition of her work, she has also been awarded the Order of the British Empire (OBE).

Publications

Eeles has authored and co-authored numerous scientific papers in prestigious journals, contributing significantly to the body of knowledge in cancer genetics. Her work is widely cited and has had a profound impact on the field.

Personal Life

Rosalind Eeles is married and has children. She continues to balance her professional commitments with her family life.

See Also

• Prostate cancer
• Genetic predisposition
• Oncology
• The Institute of Cancer Research
• The Royal Marsden NHS Foundation Trust